Dysphagia, Speech, Voice, and Trismus following Radiotherapy and/or Chemotherapy in Patients with Head and Neck Carcinoma: Review of the Literature

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Heijnen, B J ^a   Speyer, R ^a,b   Kertscher, B ^c   Cordier, R ^b,d   Koetsenruijter, K W J ^e   Swan, K ^f   Bogaardt, H ^g  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JAMES COOK UNIVERSITY   (Australia)

^c CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

^d CURTIN UNIVERSITY   (Australia)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Australian Red Cross Lifeblood   (Australia)

^g UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DYSPHAGIA; EMBASE; HEAD AND NECK CARCINOMA; HUMAN; LITERATURE; MEDLINE; QUALITY OF LIFE; REVIEW; SPEECH; SPEECH DISORDER; SYSTEMATIC REVIEW; TRISMUS; UPPER GASTROINTESTINAL TRACT; VOICE; VOICE DISORDER; AGED; CAUSALITY; CHEMORADIOTHERAPY; COMORBIDITY; DEGLUTITION DISORDERS; HEAD AND NECK NEOPLASMS; INCIDENCE; META ANALYSIS; MIDDLE AGED; RISK FACTOR; SPEECH DISORDERS; STATISTICS AND NUMERICAL DATA; VOICE DISORDERS;

AGED; CAUSALITY; CHEMORADIOTHERAPY; COMORBIDITY; DEGLUTITION DISORDERS; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MIDDLE AGED; RISK FACTORS; SPEECH DISORDERS; TRISMUS; VOICE DISORDERS;

EID: 84990960787     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/6086894     Document Type: Review

References (86)

1. A. M. Kreeft, L. Van Der Molen, F. J. Hilgers, and A. J. Balm, "Speech and swallowing after surgical treatment of advanced oral and oropharyngeal carcinoma: a systematic review of the literature, " European Archives of Oto-Rhino-Laryngology, vol. 266, no. 11, pp. 1687-1698, 2009.
2. S. N. Rogers, S. A. Ahad, and A. P. Murphy, "A structured review and theme analysis of papers published on 'quality of life' in head and neck cancer: 2000-2005, " Oral Oncology, vol. 43, no. 9, pp. 843-868, 2007.
3. R. P. Takes, P. Strojan, C. E. Silver et al., "Current trends in initial management of hypopharyngeal cancer: The declining use of open surgery, " Head and Neck, vol. 34, no. 2, pp. 270-281, 2012.
4. R. L. Nund, E. C. Ward, N. A. Scarinci, B. Cartmill, P. Kuipers, and S. V. Porceddu, "Survivors' experiences of dysphagiarelated services following head and neck cancer: implications for clinical practice, " International Journal of Language & Communication Disorders, vol. 49, no. 3, pp. 354-363, 2014.
5. R. L. Nund, E. C. Ward, N. A. Scarinci, B. Cartmill, P. Kuipers, and S. V. Porceddu, "Carers' experiences of dysphagia in people treated for head and neck cancer: a qualitative study, " Dysphagia, vol. 29, no. 4, pp. 450-458, 2014.
6. G. P. Krisciunas, W. Sokoloff, K. Stepas, and S. E. Langmore, "Survey of usual practice: dysphagia therapy in head and neck cancer patients, " Dysphagia, vol. 27, no. 4, pp. 538-549, 2012.
7. Speech Pathology Australia. Evidence-Based Practice in Speech Pathology, 2010, http://www. speechpathologyaustralia. org. au/ library/position statements/EBP in SP. pdf.
8. American Speech-Language-Hearing Association (ASHA), Evidence-Based Practice in Communication Disorders: Position Statement, 2005.
9. M. Miao, E. Power, and R. O'Halloran, "Factors affecting speech pathologists' implementation of strokemanagement guidelines: a thematic analysis, " Disability and Rehabilitation, vol. 37, no. 8, pp. 674-685, 2015.
10. J. J. Frowen and A. R. Perry, "Swallowing outcomes after radiotherapy for head and neck cancer: a systematic review, " Head and Neck, vol. 28, no. 10, pp. 932-944, 2006.
11. I. Jacobi, L. Van Der Molen, H. Huiskens, M. A. Van Rossum, and F. J. M. Hilgers, "Voice and speech outcomes of chemoradiation for advanced head and neck cancer: a systematic review, " European Archives of Oto-Rhino-Laryngology, vol. 267, no. 10, pp. 1495-1505, 2010.
12. L. Van Der Molen, M. A. Van Rossum, L. M. Burkhead, L. E. Smeele, and F. J. M. Hilgers, "Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review, " European Archives of Oto-Rhino-Laryngology, vol. 266, no. 6, pp. 889-900, 2009.
13. V. Paleri, J. W. G. Roe, P. Strojan et al., "Strategies to reduce longterm postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based review, " Head and Neck, vol. 36, no. 3, pp. 431-433, 2014.
14. J. W. G. Roe, P. N. Carding, R. C. Dwivedi et al., "Swallowing outcomes following Intensity Modulated Radiation Therapy (IMRT) for head & neck cancer-A systematic review, " Oral Oncology, vol. 46, no. 10, pp. 727-733, 2010.
15. J. Klein, J. Livergant, and J. Ringash, "Health related quality of life in head and neck cancer treated with radiation therapy with or without chemotherapy: a systematic review, " Oral Oncology, vol. 50, no. 4, pp. 254-262, 2014.
16. J. Frowen, S. Cotton, J. Corry, and A. Perry, "Impact of demographics, tumor characteristics, and treatment factors on swallowing after (chemo)radiotherapy for head and neck cancer, " Head and Neck, vol. 32, no. 4, pp. 513-528, 2010.
17. A. Liberati, D. G. Altman, J. Tetzlaff et al., "The PRISMA statement for reporting systematic reviews andmeta-Analyses of studies that evaluate health care interventions: explanation and elaboration, " PLoS Medicine, vol. 6, no. 7, Article ID e1000100, 2009.
18. L. M. Kmet, R. C. Lee, and L. S. Cook, Standard Quality Assessment Criteria for Evaluating Primary Research Papers from a Variety of Fields, 13, HTA Initiative, 2004.
19. NHMRC, A Guide to the Development, Implementation and Evaluation of Clinical Practice Guidelines, 1999.
20. D. Moher, A. Liberati, J. Tetzlaff et al., "Preferred reporting items for systematic reviews and meta-Analyses: The PRISMA statement, " PLoS Medicine, vol. 6, no. 7, Article ID e1000097, 2009.
21. L.-M. Aaltonen, N. Rautiainen, J. Sellman et al., "Voice quality after treatment of early vocal cord cancer: a randomized trial comparing laser surgery with radiation therapy, " International Journal of Radiation Oncology Biology Physics, vol. 90, no. 2, pp. 255-260, 2014.
22. A. H. Ackerstaff, A. J. M. Balm, C. R. N. Rasch et al., "First-year quality of life assessment of an intraarterial (RADPLAT) versus intravenous chemoradiation phase III trial, " Head andNeck, vol. 31, no. 1, pp. 77-84, 2009.
23. J. P. Agarwal, G. K. Baccher, C. M. Waghmare et al., "Factors affecting the quality of voice in the early glottic cancer treated with radiotherapy, " Radiotherapy and Oncology, vol. 90, no. 2, pp. 177-182, 2009.
24. A. Al-Mamgani, L. Tans, P. Van Rooij, and P. C. Levendag, "A single-institutional experience of 15 years of treating T3 laryngeal cancer with primary radiotherapy, with or without chemotherapy, " International Journal of Radiation Oncology Biology Physics, vol. 83, no. 3, pp. 1000-1006, 2012.
25. A. Al-Mamgani, P. H. van Rooij, D. P. Woutersen et al., "Radiotherapy for T1-2N0 glottic cancer: amultivariate analysis of predictive factors for the long-term outcome in 1050 patients and a prospective assessment of quality of life and voice handicap index in a subset of 233 patients, " Clinical Otolaryngology, vol. 38, no. 4, pp. 306-312, 2013.
26. A. Al-Mamgani, S. L. S. Kwa, L. Tans et al., "Single vocal cord irradiation: image guided intensity modulated hypofractionated radiation therapy for T1a glottic cancer: early clinical results, " International Journal of Radiation Oncology Biology Physics, vol. 93, no. 2, pp. 337-343, 2015.
27. M. Bansal, B. K. Mohanti, N. Shah, R. Chaudhry, S. Bahadur, and N. K. Shukla, "Radiation related morbidities and their impact on quality of life in head and neck cancer patients receiving radical radiotherapy, " Quality of Life Research, vol. 13, no. 2, pp. 481-488, 2004.
28. J. R. L. Bibby, S. M. Cotton, A. Perry, and J. F. Corry, "Voice outcomes after radiotherapy treatment for early glottic cancer: assessment using multidimensional tools, " Head and Neck, vol. 30, no. 5, pp. 600-610, 2008.
29. K. Dornfeld, J. R. Simmons, L. Karnell et al., "Radiation doses to structures within and adjacent to the larynx are correlated with long-termdiet-And speech-related quality of life, " International Journal of Radiation Oncology Biology Physics, vol. 68, no. 3, pp. 750-757, 2007.
30. I. Jacobi, A. Navran, L. van der Molen, W. D. Heemsbergen, F. J. M. Hilgers, and M. W. M. van den Brekel, "Radiation dose to the tongue and velopharynx predicts acoustic-Articulatory changes after chemo-IMRT treatment for advanced head and neck cancer, " European Archives of Oto-Rhino-Laryngology, vol. 273, no. 2, pp. 487-494, 2016.
31. T. Karlsson, M. Johansson, P. Andréll, and C. Finizia, "Effects of voice rehabilitation on health-related quality of life, communication and voice in laryngeal cancer patients treated with radiotherapy: a randomised controlled trial, " Acta Oncologica, vol. 54, no. 7, pp. 1017-1024, 2015.
32. T. Karlsson, L. Bergström, E. Ward, and C. Finizia, "A prospective longitudinal study of voice characteristics and healthrelated quality of life outcomes following laryngeal cancer treatment with radiotherapy, " Acta Oncologica, vol. 55, no. 6, pp. 693-699, 2016.
33. R. Kazi, R. Venkitaraman, C. Johnson et al., "Electroglottographic comparison of voice outcomes in patients with advanced laryngopharyngeal cancer treated by chemoradiotherapy or total laryngectomy, " International Journal of Radiation Oncology, Biology, Physics, vol. 70, no. 2, pp. 344-352, 2008.
34. P. Kerr, C. L. Myers, J. Butler, M. Alessa, P. Lambert, and A. L. Cooke, "Prospective functional outcomes in sequential population based cohorts of stage III/ IV oropharyngeal carcinoma patients treated with 3D conformal vs. intensity modulated radiotherapy, " Journal of Otolaryngology-Head and Neck Surgery, vol. 44, article 17, 2015.
35. S. A. C. Kraaijenga, L. van der Molen, I. Jacobi, O. Hamming-Vrieze, F. J. M. Hilgers, and M. W. M. van den Brekel, "Prospective clinical study on long-term swallowing function and voice quality in advanced head and neck cancer patients treated with concurrent chemoradiotherapy and preventive swallowing exercises, " European Archives of Oto-Rhino-Laryngology, vol. 272, no. 11, pp. 3521-3531, 2014.
36. C. L. Lazarus, H. Husaini, K. Hu et al., "Functional outcomes and quality of life after chemoradiotherapy: baseline and 3 and 6months post-treatment, " Dysphagia, vol. 29, no. 3, pp. 365-375, 2014.
37. B. B. Mittal, A. Kepka, A. Mahadevan et al., "Tissue/dose compensation to reduce toxicity from combined radiation and chemotherapy for advanced head and neck cancers, " International Journal of Cancer, vol. 96, pp. 61-70, 2001.
38. G. Niedzielska, A. Niedzielski, and D. Toman, "Voice after radiotherapy of the larynx carcinoma, " Radiotherapy andOncology, vol. 97, no. 2, pp. 276-280, 2010.
39. A. J. Remmelts, F. J. P. Hoebers, W. M. C. Klop, A. J. M. Balm, O. Hamming-Vrieze, and M. W. M. Van Den Brekel, "Evaluation of lasersurgery and radiotherapy as treatment modalities in early stage laryngeal carcinoma: Tumour outcome and quality of voice, " European Archives of Oto-Rhino-Laryngology, vol. 270, no. 7, pp. 2079-2087, 2013.
40. G. Sanguineti, F. Ricchetti, T. McNutt, B. Wu, and C. Fiorino, "Dosimetric predictors of dysphonia after intensity-modulated radiotherapy for oropharyngeal carcinoma, " Clinical Oncology, vol. 26, no. 1, pp. 32-38, 2014.
41. J. G. Spector, D. G. Sessions, K. S. Chao et al., "Stage I (t1N0M0) squamous cell carcinoma of the laryngeal glottis: Therapeutic results and voice preservation, " Head & Neck, vol. 21, no. 8, pp. 707-717, 1999.
42. L. Tuomi, T. Karlsson, M. Johansson, and C. Finizia, "Healthrelated quality of life and voice following radiotherapy for laryngeal cancer-A comparison between glottic and supraglottic tumours, " Acta Oncologica, vol. 54, no. 1, pp. 73-79, 2015.
43. I. M. Verdonck-de Leeuw, R. B. Keus, F. J. M. Hilgers et al., "Consequences of voice impairment in daily life for patients following radiotherapy for early glottic cancer: voice quality, vocal function, and vocal performance, " International Journal of Radiation Oncology, Biology, Physics, vol. 44, no. 5, pp. 1071-1078, 1999.
44. L. van der Molen, M. A. Van Rossum, I. Jacobi et al., "Preand posttreatment voice and speech outcomes in patients with advanced head and neck cancer treated with chemoradiotherapy: expert listeners' and patient's perception, " Journal of Voice, vol. 26, no. 5, pp. 664. e25-664. e33, 2012.
45. J. Agarwal, V. Palwe, D. Dutta et al., "Objective assessment of swallowing function after definitive concurrent (Chemo)radiotherapy in patients with head and neck cancer, " Dysphagia, vol. 26, no. 4, pp. 399-406, 2011.
46. L. M. Akst, J. Chan, P. Elson, J. Saxton, M. Strome, and D. Adelstein, "Functional outcomes following chemoradiotherapy for head and neck cancer, " Otolaryngology-Head and Neck Surgery, vol. 131, no. 6, pp. 950-957, 2004.
47. A. Al-Mamgani, R. Mehilal, P. H. Van Rooij, L. Tans, A. Sewnaik, and P. C. Levendag, "Toxicity, quality of life, and functional outcomes of 176 hypopharyngeal cancer patients treated by (Chemo)radiation: The impact of treatment modality and radiation technique, " The Laryngoscope, vol. 122, no. 8, pp. 1789-1795, 2012.
48. D. Buchbinder, R. B. Currivan, A. J. Kaplan, and M. L. Urken, "Mobilization regimens for the prevention of jaw hypomobility in the radiated patient: a comparison of three techniques, " Journal of Oral andMaxillofacial Surgery, vol. 51, no. 8, pp. 863-867, 1993.
49. J. J. Caudell, P. E. Schaner, R. A. Desmond, R. F. Meredith, S. A. Spencer, and J. A. Bonner, "Dosimetric factors associated with long-termdysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck, " International Journal of Radiation Oncology, Biology, Physics, vol. 76, no. 2, pp. 403-409, 2010.
50. M. E. M. C. Christianen, I. M. Verdonck-De Leeuw, P. Doornaert et al., "Patterns of long-termswallowing dysfunction after definitive radiotherapy or chemoradiation, " Radiotherapy and Oncology, vol. 117, no. 1, pp. 139-144, 2015.
51. E. E. W. Cohen, D. J. Haraf, M. A. List et al., "High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial, " Journal of Clinical Oncology, vol. 24, no. 21, pp. 3438-3444, 2006.
52. P. U. Dijkstra, M. W. Sterken, R. Pater, F. K. L. Spijkervet, and J. L. N. Roodenburg, "Exercise therapy for trismus in head and neck cancer, " Oral Oncology, vol. 43, no. 4, pp. 389-394, 2007.
53. F. Y. Feng, H. M. Kim, T. H. Lyden et al., "Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures, " International Journal of Radiation Oncology Biology Physics, vol. 68, no. 5, pp. 1289-1298, 2007.
54. F. Y. Feng, H. M. Kim, T. H. Lyden et al., "Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results, " Journal of Clinical Oncology, vol. 28, no. 16, pp. 2732-2738, 2010.
55. M. Haderlein, S. Semrau, O. Ott, S. Speer, C. Bohr, and R. Fietkau, "Dose-dependent deterioration of swallowing function after induction chemotherapy and definitive chemoradiotherapy for laryngopharyngeal cancer, " Strahlentherapie und Onkologie, vol. 190, no. 2, pp. 192-198, 2014.
56. K. A. Hutcheson, J. S. Lewin, F. C. Holsinger et al., "Long-term functional and survival outcomes after induction chemotherapy and risk-based definitive therapy for locally advanced squamous cell carcinoma of the head and neck, " Head and Neck, vol. 36, no. 4, pp. 474-480, 2014.
57. T. Kotz, A. D. Federman, J. Kao et al., "Prophylactic swallowing exercises in patients with head and neck cancer undergoing chemoradiation: a randomized trial, " Archives of Otolaryngology-Head and Neck Surgery, vol. 138, no. 4, pp. 376-382, 2012.
58. R. Kumar, S. Madanikia, H. Starmer et al., "Radiation dose to the floor of mouth muscles predicts swallowing complications following chemoradiation in oropharyngeal squamous cell carcinoma, " Oral Oncology, vol. 50, no. 1, pp. 65-70, 2014.
59. M. A. List, A. Siston, D. Haraf et al., "Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination, " Journal of Clinical Oncology, vol. 17, no. 3, pp. 1020-1028, 1999.
60. B. T. McLaughlin, A. S. Gokhale, Y. Shuai et al., "Management of patients treated with chemoradiotherapy for head and neck cancer without prophylactic feeding tubes: The University of Pittsburgh experience, " The Laryngoscope, vol. 120, no. 1, pp. 71-75, 2010.
61. T. Murry, R. Madasu, A. Martin, and K. T. Robbins, "Acute and chronic changes in swallowing and quality of life following intraarterial chemoradiation for organ preservation in patients with advanced head and neck cancer, " Head and Neck, vol. 20, no. 1, pp. 31-37, 1998.
62. A. Nourissat, I. Bairati, E. Samson et al., "Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer, " Cancer, vol. 116, no. 9, pp. 2275-2283, 2010.
63. S. Ottosson, U. Lindblom, P. Wahlberg et al., "Weight loss and body mass index in relation to aspiration in patients treated for head and neck cancer: a long-term follow-up, " Supportive Care in Cancer, vol. 22, no. 9, pp. 2361-2369, 2014.
64. N. Pauli, J. Johnson, C. Finizia, and P. Andréll, "The incidence of trismus and long-termimpact on health-related quality of life in patients with head and neck cancer, " Acta Oncologica, vol. 52, no. 6, pp. 1137-1145, 2013.
65. B. R. Pauloski, A. W. Rademaker, J. A. Logemann et al., "Relationship between swallow motility disorders on videofluorography and oral intake in patients treated for head and neck cancer with radiotherapy with or without chemotherapy, " Head and Neck, vol. 28, no. 12, pp. 1069-1076, 2006.
66. A. W. Rademaker, E. F. Vonesh, J. A. Logemann et al., "Eating ability in head and neck cancer patients after treatment with chemoradiation: a 12-month follow-up study accounting for dropout, " Head and Neck, vol. 25, no. 12, pp. 1034-1041, 2003.
67. J. K. Salama, K. M. Stenson, M. A. List et al., "Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer, " Archives of Otolaryngology-Head and Neck Surgery, vol. 134, no. 10, pp. 1060-1065, 2008.
68. R. Scrimger, A. Kanji, M. Parliament et al., "Correlationbetween saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy, " American Journal of Clinical Oncology, vol. 30, no. 3, pp. 271-277, 2007.
69. H. M. Starmer, D. Tippett, K. Webster et al., "Swallowing outcomes in patients with oropharyngeal cancer undergoing organ-preservation treatment, " Head and Neck, vol. 36, no. 10, pp. 1392-1397, 2014.
70. K. M. Stenson, R. Kunnavakkam, E. E. W. Cohen et al., "Chemoradiation for patients with advanced oral cavity cancer, " The Laryngoscope, vol. 120, no. 1, pp. 93-99, 2010.
71. L. Strigari, M. Benassi, G. Arcangeli, V. Bruzzaniti, G. Giovinazzo, and L. Marucci, "A novel dose constraint to reduce xerostomia in head-And-neck cancer patients treated with intensity-modulated radiotherapy, " International Journal of Radiation Oncology Biology Physics, vol. 77, no. 1, pp. 269-276, 2010.
72. J. M. Vainshtein, D. H. Moon, F. Y. Feng, D. B. Chepeha, A. Eisbruch, and M. H. Stenmark, "Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirusrelated oropharyngeal cancer, " International Journal of Radiation Oncology Biology Physics, vol. 91, no. 5, pp. 925-933, 2015.
73. L. van der Molen, M. A. van Rossum, L. M. Burkhead, L. E. Smeele, C. R. N. Rasch, and F. J. M. Hilgers, "A randomized preventive rehabilitation trial in advanced head and neck cancer patients treated with chemoradiotherapy: feasibility, compliance, and short-term effects, " Dysphagia, vol. 26, no. 2, pp. 155-170, 2011.
74. L. van der Molen, W. D. Heemsbergen, R. De Jong et al., "Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures, " Radiotherapy and Oncology, vol. 106, no. 3, pp. 364-369, 2013.
75. G. Vlacich, D. E. Spratt, R. Diaz et al., "Dose to the inferior pharyngeal constrictor predicts prolonged gastrostomy tube dependence with concurrent intensity-modulated radiation therapy and chemotherapy for locally-Advanced head and neck cancer, " Radiotherapy and Oncology, vol. 110, no. 3, pp. 435-440, 2014.
76. J. A. Wilson, P. N. Carding, and J. M. Patterson, "Dysphagia after nonsurgical head and neck cancer treatment: patients' perspectives, " Otolaryngology-Head andNeck Surgery, vol. 145, no. 5, pp. 767-771, 2011.
77. J. I. A. Urdaniz, F. A. De La Vega, A. M. Burgaleta et al., "Quality of life in patients with locally advanced head and neck cancer treated with chemoradiotherapy. Comparison of two protocols using the EORTC questionnaires (QLQ-C30, H and N35), " Clinical and Translational Oncology, vol. 7, no. 9, pp. 398-403, 2005.
78. A. Bottomley, G. Tridello, C. Coens et al., "An international phase 3 trial in head and neck cancer: quality of life and symptom results: EORTC 24954 on behalf of the EORTC head and neck and the EORTC radiation oncology group, " Cancer, vol. 120, no. 3, pp. 390-398, 2014.
79. I. M. Verdonck-De Leeuw, L. M. Buffart, M. W. Heymans et al., "The course of health-related quality of life in head and neck cancer patients treated with chemoradiation: A Prospective Cohort Study, " Radiotherapy and Oncology, vol. 110, no. 3, pp. 422-428, 2014.
80. J. A. Langendijk, P. Doornaert, I. M. Verdonck-de Leeuw, C. R. Leemans, N. K. Aaronson, and B. J. Slotman, "Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy, " Journal of Clinical Oncology, vol. 26, no. 22, pp. 3770-3776, 2008.
81. K. Jensen, A. Bonde Jensen, and C. Grau, "The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires, " Radiotherapy and Oncology, vol. 78, no. 3, pp. 298-305, 2006.
82. R. Speyer, "Effects of voice therapy: a systematic review, " Journal of Voice, vol. 22, no. 5, pp. 565-580, 2008.
83. B. H. Jacobson, A. Johnson, C. Grywalski et al., "The Voice Handicap Index (VHI), " American Journal of Speech-Language Pathology, vol. 6, no. 3, pp. 66-69, 1997.
84. P. H. Dejonckere, P. Bradley, P. Clemente et al., "A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques, " European Archives of Oto-Rhino-Laryngology, vol. 258, no. 2, pp. 77-82, 2001.
85. R. Speyer, L. Baijens, M. Heijnen, and I. Zwijnenberg, "Effects of therapy in oropharyngeal dysphagia by speech and language therapists: a systematic review, " Dysphagia, vol. 25, no. 1, pp. 40-65, 2010.
86. World Health Organization, WHO Handbook for Guideline Development, 2012, http://apps. who. int/iris/bitstream/10665/ 75146/1/9789241548441 eng. pdf.